These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1338040

  • 21. A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
    Iwanishi M, Haruta T, Takata Y, Ishibashi O, Sasaoka T, Egawa K, Imamura T, Naitou K, Itazu T, Kobayashi M.
    Diabetologia; 1993 May; 36(5):414-22. PubMed ID: 8390949
    [Abstract] [Full Text] [Related]

  • 22. A model for insulin binding to the insulin receptor.
    Schäffer L.
    Eur J Biochem; 1994 May 01; 221(3):1127-32. PubMed ID: 8181471
    [Abstract] [Full Text] [Related]

  • 23. Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.
    Gual P, Baron V, Lequoy V, Van Obberghen E.
    Endocrinology; 1998 Mar 01; 139(3):884-93. PubMed ID: 9492017
    [Abstract] [Full Text] [Related]

  • 24. The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation.
    Ward CW, Menting JG, Lawrence MC.
    Bioessays; 2013 Nov 01; 35(11):945-54, doi/10.1002/bies.201370111. PubMed ID: 24037759
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Structural characterisation of substrate binding to the human insulin receptor tyrosine kinase domain.
    Gao Y, Keane N, Levine BA, Alejos R, Ellis L.
    Biochem Soc Trans; 1992 Aug 01; 20(3):269S. PubMed ID: 1330772
    [No Abstract] [Full Text] [Related]

  • 27. Single-chain insulins as receptor agonists.
    Rajpal G, Liu M, Zhang Y, Arvan P.
    Mol Endocrinol; 2009 May 01; 23(5):679-88. PubMed ID: 19228795
    [Abstract] [Full Text] [Related]

  • 28. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.
    Varewijck AJ, Goudzwaard JA, Brugts MP, Lamberts SW, Hofland LJ, Janssen JA.
    Growth Horm IGF Res; 2010 Dec 01; 20(6):427-31. PubMed ID: 21055982
    [Abstract] [Full Text] [Related]

  • 29. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design.
    Pandyarajan V, Smith BJ, Phillips NB, Whittaker L, Cox GP, Wickramasinghe N, Menting JG, Wan ZL, Whittaker J, Ismail-Beigi F, Lawrence MC, Weiss MA.
    J Biol Chem; 2014 Dec 12; 289(50):34709-27. PubMed ID: 25305014
    [Abstract] [Full Text] [Related]

  • 30. The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase.
    Li S, Termini J, Hayward A, Siddle K, Zick Y, Koval A, LeRoith D, Fujita-Yamaguchi Y.
    FEBS Lett; 1998 Jan 02; 421(1):45-9. PubMed ID: 9462837
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Introduction of mutations in insulin molecule: positive and negative mutations].
    Ksenofontova OI.
    Biomed Khim; 2014 Jan 02; 60(4):430-7. PubMed ID: 25249526
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity.
    Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE.
    Proc Natl Acad Sci U S A; 1986 Aug 02; 83(16):5822-4. PubMed ID: 3526339
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
    Langlois WJ, Sasaoka T, Yip CC, Olefsky JM.
    Endocrinology; 1995 May 02; 136(5):1978-86. PubMed ID: 7720646
    [Abstract] [Full Text] [Related]

  • 37. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR, May FE, Westley BR.
    Eur J Biochem; 1995 Oct 01; 233(1):299-309. PubMed ID: 7588759
    [Abstract] [Full Text] [Related]

  • 38. In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase.
    Contreras I, Caro JF, Aveledo L, Diaz K, Durrego P, Weisinger JR.
    Nephron; 1992 Oct 01; 61(1):77-81. PubMed ID: 1326722
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.